ArticleOncoTargets and therapy2020

MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma.

Liantao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.